Viewing Study NCT04889768


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-24 @ 5:47 PM
Study NCT ID: NCT04889768
Status: UNKNOWN
Last Update Posted: 2021-05-17
First Post: 2021-05-12
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module